(Q45799544)

English

Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2′,5′)oligoadenylate and the cordycepin analog: Mechanism of action for inhibition of EBV-induced transformation

scientific article published on October 15, 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2′,5′)oligoadenylate and the cordycepin analog: Mechanism of action for inhibition of EBV-induced transformation (English)

reason for preferred rank

most precise value

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

Epstein–Barr virus

0 references

viral transformation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

author name string

E. E. Henderson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

P. W. Doetsch

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

R. Charubala

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

W. Pfleiderer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

R. J. Suhadolnik

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291233

18 September 2023

language of work or name

0 references

publication date

1 October 1982

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

15 October 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6291233

18 September 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0042682282903890?httpAccept=text/xml

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

https://api.elsevier.com/content/article/PII:0042682282903890?httpAccept=text/plain

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

122

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

198-201

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

1

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

1

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Surface markers on human B- and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines

3

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytes

4

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: Kinetics of EBNA expression, cellular DNA synthesis, and mitosis

5

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Characteristics of Epstein-Barr virus activation of human B lymphocytes

6

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Inhibition of virus-induced cell transformation by synthetic analogues of S-adenosyl homocysteine

8

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Inhibition of nucleoside and sugar transport into cells by an oncostatic methylase inhibitor, 5′-deoxy-5′-S -isobutyl-thioadenosine (SIBA)

9

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Anticellular and antiviral effects of pppA(2′p5′A)n

10

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Inhibition of herpes simplex virus type 2-induced biochemical transformation by interferon

11

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray-transformed C3H/10T1/2 cells under prolonged treatment with interferon

12

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

13

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate

15

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells

16

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells

19

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

A possible function of Epstein-Barr virus-determined nuclear antigen (EBNA): Stimulation of chromatin template activity in vitro

22

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein–Barr virus

23

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Epstein-Barr virus: Transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light

26

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

27

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Synthesis and characterization of (2′-5′)ppp3′dA(p3′dA)n, an analogue of (2′-5′)pppA(pA)n

28

1 reference

10.1016/0042-6822(82)90389-0

https://api.crossref.org/works/10.1016/0042-6822(82)90389-0

18 September 2023

Identifiers

10.1016/0042-6822(82)90389-0

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/6291233

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45799544&oldid=1976808079"